CAS: 300815-41-2 - 1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one hydrochloride
Formula:C21H22ClF3N2O2
InChI:InChI=1/C21H21F3N2O2.ClH/c22-21(23,24)16-7-5-15(6-8-16)9-12-26-13-10-20(11-14-26)17-3-1-2-4-18(17)25-19(27)28-20;/h1-8H,9-14H2,(H,25,27);1H
- Synonyms:
- 1'-[2-[4-(Trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one hydrochloride
Ref: IN-DA00BDSS
1mg | 117.00 € | ||
5mg | 201.00 € | ||
10mg | 230.00 € | ||
25mg | 592.00 € | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
RS-102895
CAS:300815-41-2
Formula:
C21H21F3N2O2
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
390.41
Ref: 3B-R0267
5mg | 167.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
RS102895
CAS:300815-41-2
RS102895 is a potent CCR2 antagonist (IC50: 360 nM) and shows no effect on CCR1.
Formula:
C21H21F3N2O2
Purity:
99.54%
Color and Shape:
Solid
Molecular weight:
390.4
Ref: TM-TQ0283
2mg | 43.00 € | ||
5mg | 64.00 € | ||
10mg | 94.00 € | ||
25mg | 172.00 € | ||
50mg | 249.00 € | ||
100mg | 370.00 € | ||
1mL*10mM (DMSO) | 72.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
RS 102895
Controlled ProductCAS:300815-41-2
Formula:
C21H21F3N2O2
Color and Shape:
Neat
Molecular weight:
390.399
Ref: TR-R700935
250mg | 2,146.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
RS 102895
CAS:300815-41-2
Chemokine receptor 2 (CCR2) antagonist
Formula:
C21H21F3N2O2
Purity:
Min. 95%
Molecular weight:
390.4 g/mol
Ref: 3D-FR102476
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025